TVGNW

Tevogen Bio Holdings Inc - TVGN 116项目未来5年累计营收预测约65亿美元

时间：2025-09-10 03:18:22 市场：美股综合

Tevogen Bio Enters Agreement to Receive up to $10 Million of Non-Dilutive Grant Funding

时间：2025-01-29 04:49:48 市场：美股综合

Tevogen Bio Broadens Relationship With Microsoft to Deepen Artificial Intelligence Collaboration and Develop Predictcell Technology on Azure

时间：2025-01-25 06:34:26 市场：美股综合

关联： TVGN MSFT TVGNW

Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations

时间：2024-11-09 04:36:48 市场：美股综合

关联： TVGNW TVGN

Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI Into Preclinical Processes, Accelerating Drug Development and Reducing Costs

时间：2024-10-31 22:54:56 市场：综合美股

关联： TVGN TVGNW MSFT

Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company

时间：2024-10-30 03:28:32 市场：美股综合

关联： TVGN TVGNW MSFT NDAQ

Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating Drug Development

时间：2024-10-23 20:35:00 市场：美股综合

关联： TVGNW TVGN MSFT

Tevogen Bio to Provide Timelines Associated With Recently Announced Revenue Forecast and Updates on Operational Readiness This Week

时间：2024-10-23 02:30:00 市场：美股综合

关联： TVGNW TVGN

Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion

时间：2024-10-22 03:58:24 市场：美股综合

关联： TVGNW TVGN

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow

时间：2024-10-17 21:32:57 市场：美股综合

关联： TVGNW TVGN